[The oral administration of OK-432. The 5th report: the effects on the lymphoproliferative response and natural killer cell activity in mice with transplanted cecal tumors].
D000284:Administration, Oral; D000818:Animals; D001688:Biological Products / Q000008:administration & dosage*; D002430:Cecal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D007694:Killer Cells, Natural / Q000187:drug effects*; D008213:Lymphocyte Activation / Q000187:drug effects*; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D010844:Picibanil / Q000008:administration & dosage* / Q000627:therapeutic use
D001688:Biological Products; D010844:Picibanil